← Leaderboards
Judith L. Fridovich-Keil
Emory University
$9,505,935
Attributed
$9,505,935
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $857.4K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,505,935 · 7
By mechanism
R01$7,958,421 · 3
R21$983,791 · 2
R56$391,250 · 1
P01$172,473 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Louis J Elsas$3,518,058
- Rani H Singh$952,826
- Kerry Garza$156,468
- Dean P. Jones$29,823,845
- Jason R Richardson$15,517,223
Others in their field
Top investigators on “Galactose”
- John V Fahy · University Of California San Francisco$17,627,162
- Jamey Marth · Sanford Burnham Prebys Medical Discovery Institute$13,200,239
- Jan Novak · University Of Alabama At Birmingham$11,998,798
- Michael Demetriou · University Of California-Irvine$10,040,509
- Thomas A. Platts-Mills · University Of Virginia$9,385,605
- Edward I Solomon · Stanford University$8,901,198
Research focus
GalactoseGalactosemiasPhenotypePreventClassical GalactosemiaDietary RestrictionFunctional DisorderBaseAcuteBiochemicalDisabilityBiological ModelsCognitiveFemaleExposure ToEarly DiagnosisCohortEffective TherapyGlycosylationImpairmentMetabolicPlasmaDefectGenotype
Grant awards (43)
Improving the reach and efficacy of gene therapy by in vivo EV targeting$430,375
R21 · FY2025 · HD · contact PI
Gene Therapy in a GALT-null Rat Model of Classic Galactosemia$195,625
R56 · FY2025 · DK · contact PI
Gene Therapy in a GALT-null Rat Model of Classic Galactosemia$195,625
R56 · FY2024 · DK · contact PI
Mechanism, Modification, and Intervention in a Pre-Clinical Model of Galactosemia$449,357
R01 · FY2019 · DK · contact PI
Mechanism, modification, and intervention in a pre-clinical model of galactosemia$412,989
R01 · FY2018 · DK · contact PI
A Animal model for studies of galactosemia$231,971
R21 · FY2018 · HD · contact PI
A Animal model for studies of galactosemia$65,250
R21 · FY2018 · HD · contact PI
Mechanism, modification, and intervention in a pre-clinical model of galactosemia$28,004
R01 · FY2018 · DK · contact PI
Mechanism, modification, and intervention in a pre-clinical model of galactosemia$454,383
R01 · FY2017 · DK · contact PI
A Animal model for studies of galactosemia$193,155
R21 · FY2017 · HD · contact PI
A rat model for studies of galactosemia$63,040
R21 · FY2017 · HD · contact PI
Mechanism, modification, and intervention in a pre-clinical model of galactosemia$405,524
R01 · FY2016 · DK · contact PI
Mechanism, modification, and intervention in a pre-clinical model of galactosemia$23,876
R01 · FY2016 · DK · contact PI
Bases of Pathophysiology in Galactosemia$373,784
R01 · FY2011 · DK · contact PI
A D. melanogaster model for galactosemia$303,831
R01 · FY2011 · DK · contact PI
A D. melanogaster model for galactosemia$327,033
R01 · FY2010 · DK · contact PI
Bases of Pathophysiology in Galactosemia$319,419
R01 · FY2010 · DK · contact PI
Bases of Pathophysiology in Galactosemia$154,463
R01 · FY2010 · DK · contact PI
Bases of Pathophysiology in Galactosemia$56,446
R01 · FY2010 · DK · contact PI
Bases of Pathophysiology in Galactosemia$328,846
R01 · FY2009 · DK · contact PI
A D. melanogaster model for galactosemia$310,000
R01 · FY2009 · DK · contact PI
Bases of Pathophysiology in Galactosemia$55,025
R01 · FY2009 · DK · contact PI
A D. melanogaster model for galactosemia$8,990
R01 · FY2009 · DK · contact PI
Bases of Pathophysiology in Galactosemia$322,646
R01 · FY2008 · DK · contact PI
A D. melanogaster model for galactosemia$298,411
R01 · FY2008 · DK · contact PI
Bases of Pathophysiology in Galactosemia$14,136
R01 · FY2008 · DK · contact PI
Bases of Pathophysiology in Galactosemia$340,095
R01 · FY2007 · DK · contact PI
Bases of Pathophysiology in Galactosemia$13,481
R01 · FY2007 · DK · contact PI
Studies of Galactose Toxicity in Yeast and Human Cells$241,242
R01 · FY2006 · DK · contact PI
Human Enzymes Underlying Galactosemia$238,877
R01 · FY2006 · DK · contact PI
Studies of Galactose Toxicity in Yeast and Human Cells$247,047
R01 · FY2005 · DK
Human Enzymes Underlying Galactosemia$244,626
R01 · FY2005 · DK
Human Enzymes Underlying Galactosemia$12,988
R01 · FY2005 · DK
Studies of Galactose Toxicity in Yeast and Human Cells$247,047
R01 · FY2004 · DK
Human Enzymes Underlying Galactosemia$244,626
R01 · FY2004 · DK
Studies of Galactose Toxicity in Yeast and Human Cells$247,047
R01 · FY2003 · DK
Human Enzymes Underlying Galactosemia$224,919
R01 · FY2003 · DK
Human Enzymes Underlying Galactosemia$9,120
R01 · FY2003 · DK
Human Enzymes Underlying Galactosemia$351,500
R01 · FY2002 · DK
Studies of Galactose Toxicity in Yeast and Human Cells$251,936
R01 · FY2002 · DK
HUMAN ENZYMES UNDERLYING GALACTOSEMIA$201,286
R01 · FY2001 · DK
MOLECULAR STUDIES OF FMRP FUNCTION IN YEAST$172,473
P01 · FY2001 · HD
HUMAN ENZYMES UNDERLYING GALACTOSEMIA$195,421
R01 · FY2000 · DK